Abzu and Contera Pharma expand strategic partnership - #BHHMembersInitiatives
Home News Abzu and Contera Pharma expand strategic partnership - #BHHMembersInitiatives

Abzu and Contera Pharma expand strategic partnership - #BHHMembersInitiatives

APRIL 19, 2023 Members' News

BHH member Abzu® and Contera Pharma expand their strategic partnership to add drug-target identification to their seminal RNA- and siRNAs therapeutic design platform. Contera Pharma is a Danish biotech company developing innovative small-molecule and RNA-based therapeutics to address neurological disorders.

Their unique R&D model integrates their team of experienced neuroscience drug hunters with cutting-edge technology, like Abzu’s proprietary discovery engine, the QLattice®, to develop precision medicines. Abzu’s QLattice, a new class of explainable artificial intelligence with recently-patented technology, accelerates scientists’ exploration and understanding of relationships in data. Abzu and Contera Pharma initially collaborated in July 2021 to incorporate the QLattice into an RNA therapeutic design application.

The application designs RNA therapeutics through parallel hypotheses testing of drug targets and individual antisense oligonucleotide (ASO) drug properties. After seeing accelerated progress on two undisclosed therapeutics currently in preclinical testing, Abzu and Contera Pharma agreed to expand their strategic partnership, adding siRNAs and target identification to the platform. "Our expanded strategic partnership is based on a three-pronged approach to strengthen our drug discovery platform: First, we run ASO drug design by automation; second, we will add siRNAs as an RNA therapeutic modality; and third, we identify novel targets with Abzu’s explainable artificial intelligence," says Kenneth Christensen, Chief Scientific Officer of Contera Pharma.

"We want to turbocharge the development of RNA medicines," says Martin Kerr, Head of Business Development and Pharma Partnerships at Abzu. "With Contera Pharma, we’re designing and testing RNA medicines to multiple targets — all at once — which means that we’re breaking new ground faster than anyone else."

Combined, this expanded partnership advances the companies vision to accelerate the drug discovery process by deepening the disease and disease-target understanding and at the same time accelerating rational drug design.

Read more HERE.  

November 13, 2026 Members' News
Fund It, Build It, Certify It: A MedTech Startup's Roadmap to Market
Most MedTech startups don't stall because the technology fails. They stall because funding and regulation were planned separately. Under MDR, compliance is not the last step before submission. It shapes your product and company decisions from day one. And investors know it: before a Series A or B, they expect a credible regulatory strategy, not just a promising prototype. That's why, QbD Group and Capital Cell teamed up, to bring both sides together in one free webinar live session.
Read more
November 13, 2026 Members' News
The Ultimate Guide for Choosing an Enterprise CMS
In strictly regulated industries like pharmaceutical and health insurance, delivering seamless, compliant digital experiences—from patient portals to provider resources—is critical. Magnolia is a leading composable Digital Experience Platform (DXP) trusted by healthcare and global enterprise giants like Sanofi and Generali. By centralizing websites, portals, and apps into one intuitive, open platform, Magnolia's CMS empowers IT teams to build freely and marketing teams to launch faster—all while protecting brand integrity and compliance.
Read more
November 12, 2026 Members' News
Your Next Innovation May Already Exist
Connecting business challenges with scientific knowledge
Read more
November 12, 2026 Members' News
Health Tech Enterprise launches half-price UK market entry offer for Barcelona & Madrid Health Hub members
Health Tech Enterprise introduces an exclusive UK Market Entry Pathfinder offer for Barcelona & Madrid Health Hub members, helping MedTech companies assess their readiness for UK expansion and receive an evidence-based market entry recommendation within 21 days, with preferential member pricing available until 31 December 2026.
Read more
November 04, 2026 Members' News
NeuronUP Academy, Barcelona Health Hub and Madrid Health Hub launch 60 scholarships in neuropsychology and neurorehabilitation
The joint initiative offers 60 scholarships for university programmes endorsed by EUNEIZ Universidad, with additional discounts guaranteed for Hub members.
Read more
October 05, 2026 Members' News
Aurela brings together mental health stakeholders to discuss how to design services around people’s real needs
An event bringing together voices from across the healthcare system to discuss how to ensure that everyone has access to the care they truly need. To mark World Mental Health Day and its 2026 theme, Lived experiences heard: real voices, real change, on October 7 we hosted a gathering at Barcelona Health Hub bringing together people with lived experience, therapists, and organisations to explore what needs to change to ensure mental health services truly respond to people’s needs.
Read more
October 05, 2026 Members' News
MSD in Spain joins Barcelona & Madrid Health Hub to drive digital health innovation
MSD in Spain has signed an agreement to join Barcelona & Madrid Health Hub, taking another step forward in its commitment to digital health innovation, an area in which the Company has been working for some time.
Read more
September 21, 2026 Members' News
Sykah introduces virtual workers that eliminate administrative burden from pharma companies
Today, in most plants, admin work eats the real work. Incident reports on paper. Data copied by hand between excels. Hours of process documentation nobody has time to maintain. The result: skilled technicians doing office work, and decisions made late or on incomplete information.
Read more
September 21, 2026 Members' News
Skinive expands AI-powered skin analysis platform with new UV Protection & Monitoring features
Barcelona, Spain Skinive, a member of Barcelona Health Hub, has announced a major update to its AI-powered skin health platform with the launch of new UV Protection & Monitoring features for iOS and Android. The latest release helps people better understand daily ultraviolet (UV) exposure and make more informed decisions about sun protection during periods of high UV radiation and extreme summer temperatures.
Read more
September 11, 2026 Members' News
Barcelona Health Hub Member InnHealthium Helps MedTech Companies Prepare for the EU AI Act
Barcelona Health Hub member InnHealthium is bringing together experts in AI-enabled medical devices, standards development, QA/RA and conformity assessment for a dedicated event at Barcelona Health Hub on September 22, helping the MedTech ecosystem prepare for the practical impact of the EU AI Act.
Read more